Differential Regulation of Estrogen Receptor Subtypes α and β in Human Aortic Smooth Muscle Cells by Oligonucleotides and Estradiol

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 5, 2004, Pages 2373-2381

  Barchiesi, Federica ^a   Jackson, Edwin K ^b   Imthurn, Bruno ^a   Fingerle, Juergen ^c   Gillespie, Delbert G ^b   Dubey, Raghvendra K ^a,b,d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c Preclinical Pharma Research 68/209   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; 2 METHOXYESTRADIOL; ANTIMITOTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; OLIGONUCLEOTIDE; PROTEASOME; RECEPTOR SUBTYPE;

AORTA; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DEGRADATION; DOWN REGULATION; FEMALE; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR GENE; SMOOTH MUSCLE FIBER;

AORTA; CELL DIVISION; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MULTIENZYME COMPLEXES; MUSCLE, SMOOTH, VASCULAR; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, ESTROGEN;

EID: 2442476071     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030821     Document Type: Article

References (44)

1. Dubey RK, Jackson EK 2001 Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol 280:F365-F388
2. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-613
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
4. Pare G, Krust A, Karas RH, Dupont S, Aronavitz M, Chambon P, Mendelsohn ME 2002 Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Circ Res 90:1087-1092
5. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thorén P, Smithies O, Gustafsson JA, Mendelsohn ME 2002 Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science 295:505-508
6. Ogawa S, Emi M, Hosoi T, Ouchi Y, Inoue S 2000 Association of estrogen receptor β (ESR2) gene polymorphism with blood pressure. J Hum Genet 45:327-330
7. Kaneko K, Furlow JD, Gorski J 1993 Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation. Mol Endocrinol 7:879-888
8. Tschugguel W, Dietrich W, Zhegu Z, Stonek F, Kolbus A, Huber JC 2003 Differential regulation of proteosome-dependent estrogen receptor α and β turnover in cultured human uterine artery endothelial cells. J Clin Endocrinol Metab 88:2281-2287
9. Wijayaratne AL, McDonnell DP 2001 The human estrogen receptor-α is a ubiquinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 2001:35684-35692
10. Lonard DM, Nawaz Z, Smith CL, O'Malley BW 2000 The 26S proteasome is required for estrogen receptor α and coactivator turn over and for efficient ERα transactivation. Mol Cell 5:939-948
11. Alarid ET, Bakopoulos N, Solodin N 1999 Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13:1522-1534
12. Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmonskol M, Puente M, Martin MB 1988 Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2:1157-1162
13. Santagati S, Gianazza E, Agrati P, Vegeto E, Patrone C, Pollio G, Maggi A 1997 Oligonucleotide squelching reveals the mechanism of estrogen receptor autologous down-regulation. Mol Endocrinol 11:938-949
14. Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ 2003 Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J Biol Chem 278:18811-18816
15. Lin YW, Chuang SM, Yang JL 2003 ERK 1/2 achieves sustained activation by stimulating MAPK-phosphatase-1 degradation via the ubiquitin- proteasome pathway. J Biol Chem 278:21534-21541
16. Knauthe R, Diel P, Hegele-Hartung C, Engelhaupt A, Fritzemeier KH 1996 Sexual dimorphism of steroid hormone receptor messenger ribonucleic acid expression and hormonal regulation in rat vascular tissue. Endocrinology 137:3220-3227
17. Jesmin S, Hattori Y, Sakuma I, Liu MY, Mowa CN, Kitabatake A 2003 Estrogen deprivation and replacement modulate cerebral capillary density with vascular expression of angiogenic molecules in middle-aged female rats. J Cereb Blood Flow Metab 23:181-189
18. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson C, Enmark E, Pettersson K, Warner M, Gustafsson JA 2001 Mechanisms of estrogen action. Physiol Rev 81:1535-1565
19. Ihionkhan CE, Chambliss KL, Gibson LL, Hahner LD, Mendelsohn ME, Shaul PW 2002 Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res 91:814-820
20. Dauvois S, Danielian PS, White R, Parker MG 1992 Antiestrogen ICI164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89:4037-4041
21. Hodges YK, Tung L, Yan X-D, Graham D, Horwitz KB, Horwitz LD 2000 Estrogen receptors α and β. Prevalence of estrogen receptor β mRNA inhuman vascular smooth muscle and transcriptional effects. Circulation 101:1792-1798
22. Maggi A, Cignarella A, Brusadelli A, Bolego C, Pinna C, Puglisi L 2003 Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-β. Circulation 108:211-217
23. Dubey RK, Gillespie DG, Zacharia LC, Imthurn B, Jackson EK, Keller PJ 2000 Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and MAP kinase activity. Arterioscler Thromb Vasc Biol 20:964-972
24. Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS 2002 Antagonists selective for estrogen receptor α. Endocrinology 143:941-947
25. Harris HA, Katzenellenbogen JA, Katzenellenbogen BS 2002 Characterization of the biological roles of the estrogen receptors, ERα, and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand. Endocrinology 143:4172-4177
26. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230-4251
27. Dubey RK, Gillespie DG, Zacharia LC, Barchiesi F, Imthurn B, Jackson EK 2003 CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs. Hypertension 41:807-813
28. Noah DL, Blum MA, Sherry B 1998 Transfection of primary cardiac myocyte cultures with DNA and anti-sense oligonucleotides using FuGENE 6 transfection reagent. Biochemica 2:38-40
29. Williard R, Benz CC, Baxter JD, Kushner P, Hunt CA 1994 Paradoxical production of target protein using antisense RNA expression vectors. Gene 149:21-24
30. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner P, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
31. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang C, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM 1999 Estrogen receptor (ER) modulators each induce distinct conformational changes in ERα and ERβ. Proc Natl Acad Sci USA 96:3999-4004
32. Yi P, Driscoll MD, Huang J, Bhagat S, Hilf R, Bambara RA, Muyan M 2002 The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ERα and ERβ. Mol Endocrinol 16:674-693
33. Marsaud V, Gougelet A, Maillard S, Renoir J-M 2003 Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor α (ERα), differentially affect ERα extractability, proteasome-mediated stability and transcriptional activity in human breast cancer cells. Mol Endocrinol 17:2013-2027
34. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D 2001 Hyperactivation of MAPK induces loss of ERα expression in breast cancer cells. Mol Endocrinol 15:1344-1359
35. Geraldes P, Sirois MG, Tanguay J-F 2003 Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res 93:399-405
36. Webb P, Lopez GN, Greene GL, Baxter JD, Kushner PJ 1992 The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol 6:157-167
37. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR 1987 Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1:68-74
38. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, O'Donnel TF, Korach KS, Mendelsohn ME 1997 Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nat Med 3:545-548
39. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, Gustafsson JA, Korach KS, Smithies O, Mendelsohn ME 1999 Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc Natl Acad Sci USA. 96:15133-15136
40. Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME 2001 Effects of estrogen on the vascular injury response in estrogen receptor α,β (double knockout) mice. Circ Res 89:534-539
41. Oparil S, Levine RL, Chen SJ, Durand J, Chen YF 1997 Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulation 95:1301-1307
42. Zacharia LC, Karagiorgou M, Gogos JA, Jackson EK, Gilliespie DG, Barchiesi F, Dubey RK 2003 Methoxyestradiols mediate the antimitogenic effects of 17β-estradiol: direct evidence from the COMT knockout mice. Circulation 108:2974-2978
43. Ali SH, O'Donnell AL, Mohamed S, Mousa S, Dandona P 1999 stable overexpression of estrogen receptor-α in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor. Mol Cell Endocrinol 152:1-9
44. Martin JH, Begum S, Alalami O, Harrison A, Scott KW 2000 Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumour Biol 21:90-97